SUBSCRIBE
SUBSCRIBE
News   Policy

Cornerstone Therapeutics Inc. Gets U.S. FDA Warning

November 23, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. regulators warned Cornerstone Therapeutics that the company has distributed drugs without approved applications, a letter released on Friday said.
Regulatory
Food and Drug Administration (FDA) Chiesi, USA
MORE ON THIS TOPIC
screenshot of Marty Makary speaking on the Megyn Kelly Show
Regulatory
Makary Doubles Down on Push To ‘Modernize’ FDA, Eyes Speedier Reviews
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Drug pricing
Senate Republicans Drop Orphan Drug Exemptions From ‘One Big Beautiful Bill’
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics
June 18, 2025
 · 
1 min read
 · 
Heather McKenzie
Bureaucracy and administration management success with a group of tangled red tape and people running away on a pencil drawing line as a bureaucratic solution symbol with 3D illustration elements.
FDA
FDA Rolls Out Commissioner’s Priority Voucher Program to Speed Drug Reviews
June 17, 2025
 · 
2 min read
 · 
Annalee Armstrong